Investor Presentaiton

The Future of Viral Vector Manufacturing Standard is Here! Current viral vector manufacturing approaches require large quantities of expensive plasmids Current methods struggle to scale above 200L Esinors sledk .000 sartoriusstedim Plasmid-Free, Fully Scalable Manufacturing of Lentiviral Vectors (LVV) & Adeno-Associated Virus (AAV) 200L Bioreactor 1000L Bioreactor Our technologies remove the need for plasmids and reduce the costs of manufacturing Our new technologies can be scaled >2000L ? Wuxi AppTec 药明康德

View entire presentation